Ambey Laboratories Limited (NSE:AMBEY)
India · Delayed Price · Currency is INR 41.25
0.00 (0.00%)
At close: Sep 29, 2025
Ambey Laboratories Revenue
In the fiscal year ending March 31, 2025, Ambey Laboratories had annual revenue of 1.33B INR with 9.00% growth. Ambey Laboratories had revenue of 644.74M in the half year ending March 31, 2025.
Revenue
1.33B
Revenue Growth
+9.00%
P/S Ratio
0.79
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.33B | 109.70M | 9.00% |
| Mar 31, 2024 | 1.22B | 144.54M | 13.45% |
| Mar 31, 2023 | 1.07B | 225.73M | 26.59% |
| Mar 31, 2022 | 849.05M | 27.82M | 3.39% |
| Mar 31, 2021 | 821.23M | 150.82M | 22.50% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Bajaj Finance | 387.76B |
| Infosys | 1,672.76B |